Today, CLSA applauded Gov. Jerry Brown for signing Senate Bill 212, legislation to establish a statewide drugs and sharps take-back program. SB 212 was approved by the California Legislature earlier this year and signed Sept. 30, by Brown.
CLSA applauds the U.S. House passage of H.R. 6378, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018, legislation which is critical for safeguarding our nation’s biodefense and pandemic preparedness enterprise.
CLSA today applauded Gov. Jerry Brown for signing Senate Bill 1121, legislation that helps protect clinical trials conducted in California, which are the lifeblood of new and innovative medicines to treat patients in need. SB 1121 was approved by the California Legislature earlier this year and signed into law yesterday, Sept. 24, by Brown.
California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, and California Life Sciences Institute (CLSI) today announced that Los Altos High School has been selected as the winner of the Giants of Science competition, a program that awards $20,000 to a deserving Bay Area high school to support STEM education and the next generation of life sciences leaders. Moving into its 3rd year, Giants of Science is hosted by KNBR, CLSA and CLSI – the non-profit partner of CLSA which supports workforce development, STEM education and entrepreneurship.
Today, CLSA announced the recipients of the 2018 Pantheon DiNA™ Awards. This prestigious and long-running awards program, now in its 15th year, brings together nearly 1,000 industry pioneers to recognize the achievements of those dedicated to advancing California’s life sciences community.
California Life Sciences Association (CLSA) today urged Governor Jerry Brown to sign Senate Bill 1121, legislation that helps protect clinical trials conducted in California, which are the lifeblood of new and innovative medicines to treat patients in need. SB 1121 was approved by the California Legislature earlier this year and awaits action by Governor Brown, who has until Sept. 30 to sign or veto the legislation.
Today, CLSA announced the launch of “Faces of California Biomedical Innovation,” a digital campaign and website to elevate and amplify California patient voices and showcase the impact of innovative cures and treatments developed by the California life sciences industry.
Today, CLSA applauded the U.S. House passage of H.R. 184, the Protect Medical Innovation Act, which permanently repeals the job and innovation hindering 2.3% medical device excise tax levied on medical technology companies.
CLSA is proud that hundreds of our innovative member companies call the Bay Area home, and we look forward to working with Mayor-elect London Breed and her Administration to advance thoughtful policies that will grow and ensure the vibrancy of San Francisco’s treasured life sciences ecosystem.
2018 – 2019 state budget includes $30 million for Precision Medicine Research